周二盘中，吉利德科学（GILD）股价大幅下挫，截至发稿时跌幅达5.02%。这一显著跌幅与美国总统特朗普关于医药成本的最新言论密切相关。
据报道，特朗普表示将于下周公布降低药品成本的计划。这一消息立即引发了制药业的担忧，导致多家制药公司股价下跌。特朗普还提到，他计划在未来两周内宣布对药品征收关税的措施，进一步加剧了市场的紧张情绪。
吉利德科学作为制药行业的重要成员，无疑受到了这一消息的直接影响。除吉利德外，其他大型制药公司如礼来、艾伯维、默克等的股价也出现不同程度的下跌。分析人士认为，特朗普的这一举措可能会对整个制药行业的盈利能力产生重大影响，投资者对此反应强烈。随着更多细节的公布，市场将密切关注这些政策对制药公司长期发展的潜在影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.